BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

697 related articles for article (PubMed ID: 18004078)

  • 21. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
    Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
    Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
    Kim BS; Oh ST; Yook JH; Kim BS
    Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients.
    Wang JY; Hsieh JS; Huang CJ; Huang YS; Huang TJ
    J Surg Oncol; 1996 Sep; 63(1):36-40. PubMed ID: 8841464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marked elevation of plasma carcinoembryonic antigen and stomach carcinoma.
    Horie Y; Miura K; Matsui K; Yukimasa A; Ohi S; Hamamoto T; Kawasaki H
    Cancer; 1996 May; 77(10):1991-7. PubMed ID: 8640661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary signet ring cell carcinoma of colorectum: an age- and sex-matched controlled study.
    Tung SY; Wu CS; Chen PC
    Am J Gastroenterol; 1996 Oct; 91(10):2195-9. PubMed ID: 8855747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features of signet-ring cell carcinoma of the colon and rectum: a case-matched study.
    Min BS; Kim NK; Ko YT; Baek SH; Lee KY; Sohn SK; Cho CH; Kang DR
    Hepatogastroenterology; 2009; 56(93):984-8. PubMed ID: 19760925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features of long-term survivors of scirrhous gastric cancer.
    Takahashi I; Matsusaka T; Onohara T; Nishizaki T; Ishikawa T; Tashiro H; Wakasugi K; Kume K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2000; 47(35):1485-8. PubMed ID: 11100383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathology and prognosis of mucinous gastric carcinoma.
    Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
    Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological study of mucinous gastric carcinoma.
    Shibuya H; Nishida R; Koide S; Kurokawa J; Okita K
    Ann Chir Gynaecol; 2000; 89(4):273-6. PubMed ID: 11204957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors of advanced gastric carcinoma without serosal invasion (pT2 gastric carcinoma).
    Isozaki H; Fujii K; Nomura E; Mabuchi H; Nishiguchi K; Hara H; Tanigawa N
    Hepatogastroenterology; 1999; 46(28):2669-72. PubMed ID: 10522062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma.
    Lee SH; Jee SR; Kim JH; Seol SY
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):170-4. PubMed ID: 25503738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic features of gastric carcinoma patients who undergo a total gastrectomy.
    Joo JK; Kim HG; Ryu SY; Lee JH; Kim DY
    Int Surg; 2010; 95(2):147-52. PubMed ID: 20718322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
    Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
    Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
    Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
    Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
    Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
    Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrilsin expression is a useful marker of submucosal invasion and lymph node metastasis in early stage signet ring cell carcinoma of the stomach.
    Aihara R; Mochiki E; Kamiyama Y; Ohno T; Asao T; Kuwano H
    J Surg Oncol; 2006 May; 93(6):491-7. PubMed ID: 16615152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.